Sea King Biological Sanchi, the concept of swine flu near the end of speculation

Absrtact: Yesterday, Sea King biological and other swine flu medicine stocks still staged a roller-like shipping market.　　Some investors, still optimistic about the pandemic, acted as a player and were bombarded by a profit-making spree all day. Yesterday, Sea King biological and other swine flu medicine stocks still staged a roller-like shipping market. Some investors, still optimistic about the pandemic, acted as a player and were bombarded by a profit-making spree all day. Out of control elevator-like trend, but also let the power of both empty both fully released. One of the Sea King Bio-day stock price ups and downs, in about 10% of the vibration space Sanchi, the whole day turnover rate as high as 31.07%.　　In this regard, many people in the industry think that the main shipments of obvious signs, the proposed investors to avoid. The main stream of wild swine flu theme stocks opened soon, the Sea King creature will go all the way down, straight to the drop. Shanghai Kirin Good Asset Management Co., Ltd. President Zhonglin reporters: from the plate, it is clear that the main force in the crazy shipments.　　transactions, some small and medium-sized investors in the Sea King fell, also have to buy to grab chips. But soon the stock price, like a runaway elevator, suddenly soared, rising about 10%. Throughout the Sea King biological trend, a total of three times ups and downs. Some of the investors worried about the quilt are short of breath.　　From the plate surface can be seen, the same plate of the Hualan creature in the afternoon suddenly at almost 90 degrees right angle, pull 10 points higher. "Fill up the warehouse now!" Shenzhen, a shareholder plate repeatedly told friends. And after the close he was somewhat helpless to introduce, "originally planned to sell early in the morning, but the afternoon saw the Hualan creature suddenly pulled up, led bio-pharmaceutical stocks began to soar, I changed to buy." Only medium-term holdings can now be planned. "From the data analysis, yesterday, the main stock of flu medicine fled the signs more obvious, are the main fund net outflow."　　Great wisdom TopView yesterday after the disk statistics show: Sea King yesterday, the main fund net outflow of 37 million yuan, turnover 136.48 million shares, change hand rate as high as 31.07%.　　Hualan yesterday the main fund outflow of 40 million yuan, accounting for the circulation of 0.32%, turnover 31.26 million shares, change hand rate of 9%.　　The second half of bio-pharmaceutical still have market because of the early frying, industry analysts think the hot money speculation is nearing the end of the flow. Wang Qian studied, an analyst with the Great Wall securities and pharmaceutical industry, said: The overall pharmaceutical sector, the second half there are some. In the context of the expected economic recovery. The pharmaceutical industry should grow by about 20%.　　In addition, the end of this month should be out of the basic drug catalogue, the fundamentals should not be too panic. The swine flu market should not end, but the DA an gene to do testing reagents, the impact of the swine flu is not big, the market should be basically over.　　Do a swine flu vaccine of the Temple of Biology, Sea King Biology, there should be some market, but now is the end of the hype. She believes that biopharmaceutical may still be in the second half of the market, but the focus should not be on the swine flu, but should be in the asset injection or restructuring.　　For example, the Temple of Heaven life, major shareholders will be blood products injected into the assets. Century Securities analyst Chen Dongli said:Sea King Biology, such as bio-pharmaceutical stocks, speculative very strong, a large increase in the proposal to avoid investors. Recent shipments of suspicion, high volume stagnation phenomenon is more serious. There may be a spike in the future, but the space is small.　　In particular, such as Hualan biological blue, the current volume of large shocks, indicating that the funds in the previous fund does not recognize this hype reason. He said that Hualan has been a representative of Blue since its listing in 04 and has been held by the Fund's heavy warehouse. If the swine flu vaccine really brings good benefits to the company, the rally should be very easy to recognize. But at present has been heavy, and amplitude is very large, there is a deliberate attraction market eyeball suspicion. Recently, Hualan biological volume greatly concussion. And the fund won't play that hard. This means that the floating capital is fleeing. Besides, he is already very high in P/E. ”